SHUKRA PHARMACEUTICALS
|
The Current P/E Ratio of SHUKRA PHARMACEUTICALS is 54.21.
| Share Price | ₹44.5 | Sep 01,2026 |
| Market Cap | ₹1,954.0 Cr | |
| Earnings-TTM | ₹36.0 Cr | TTM-Standalone Results |
| Price/Earnings | 54.21x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SHUKRA PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,954.0 Cr] as on Sep 01,2026
(/) Earnings [ ₹36.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 54.21x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay 54.21 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHUKRA PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SHUKRA PHARMACEUTICALS
PE Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 22.35x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 99.91x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0.48x.
How does SHUKRA PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SHUKRA PHARMACEUTICALS | 36.05 | 54.21 | 1,954.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.05 | 463,180.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 83.18 | 243,302.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.49 | 188,623.0 |
| CIPLA LTD | 3,364.84 | 34.04 | 114,554.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.84 | 97,741.0 |
| MANKIND PHARMA LTD | 2,055.11 | 47.43 | 97,467.0 |
| LUPIN LTD | 5,551.01 | 17.71 | 98,312.2 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.85 | 116,114.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.08 | 96,836.1 |
| LAURUS LABS LTD | 1,090.76 | 92.14 | 100,498.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHUKRA PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.71x |
| Max industry PE | 92.14x |
| Median industry PE | 38.05x |
| Average industry PE | 48.82x |
You may also like the below Video Courses